Hussman Strategic Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$20.7M |
| 2 |
Chevron
CVX
|
+$20.7M |
| 3 |
STJ
St Jude Medical
STJ
|
+$20.3M |
| 4 |
Labcorp
LH
|
+$19.9M |
| 5 |
McDonald's
MCD
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$29.5M |
| 2 |
Colgate-Palmolive
CL
|
+$23.7M |
| 3 |
Generac Holdings
GNRC
|
+$23.2M |
| 4 |
Murphy Oil
MUR
|
+$21.9M |
| 5 |
Mattel
MAT
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.9% |
| 2 | Technology | 18.98% |
| 3 | Consumer Discretionary | 12.11% |
| 4 | Consumer Staples | 9.66% |
| 5 | Industrials | 7.12% |
Similar funds
Hussman Strategic Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, Hussman Strategic Advisors held 242 positions worth $1.4B, down 23% from $1.82B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Hussman Strategic Advisors withdrew a net $548M in Q4 2013, closing 45 positions and reducing 67 holdings. Its most notable exit was Colgate-Palmolive, an estimated $23.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Hussman Strategic Advisors opened a new position in St Jude Medical worth $21.7M.
- Hussman Strategic Advisors's largest Q4 2013 buy was St Jude Medical: 350,000 shares worth $21.7M.
- Hussman Strategic Advisors added most to GSK in Q4 2013, an estimated $20.7M increase.
- Hussman Strategic Advisors's biggest Q4 2013 reduction was Aflac, cutting an estimated $29.5M.
- Hussman Strategic Advisors fully exited Colgate-Palmolive in Q4 2013, selling an estimated $23.7M.
- Hussman Strategic Advisors's ten largest holdings make up 16% of its $1.4B portfolio in Q4 2013.
- Hussman Strategic Advisors opened 35 new positions and closed 45 in Q4 2013.
- Hussman Strategic Advisors's portfolio value fell 23% quarter-over-quarter to $1.4B.
Based on Hussman Strategic Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.